Novartis Ag ADR (NVS)
$108.12
1.99 (1.88%)
NVS Stock Quote Delayed 30 Minutes
Amgen, Inc. (AMGN) Q4 Earnings Preview
Amgen (AMGN) reports Q4 earnings on Thursday, and if something does weigh on AMGN stock, it'll likely be one of these three factors.
Top 5 Stocks for 2024
INSIDE: Investing legend Louis Navellier reveals his Top 5 Stocks for 2024 — FREE!
Download His Free Report Here:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Unlock Louis Navellier's
? Stock Report – FREE:
Is ? a BUY?
Powered by Portfolio Grader
A
B
C
D
F
?
Unlock Louis Navellier's
? Stock Report to Find Out – FREE:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Investing legend Louis Navellier rates ? a "?." Unlock his ? Stock Analysis to find out why – FREE:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Fundamental Grade
Quantitative Grade
- Sales Growth ?
- Operating Margin Growth ?
- Earnings Growth ?
- Earnings Momentum ?
- Earnings Surprises ?
- Analyst Earnings Revisions ?
- Cash Flow ?
- Return on Equity ?
Previous Close
-
Market Cap
-
PE Ratio
-
EPS
-
Volume (Avg. Vol.)
586,220
Day's Range
$107.59 - $108.34
52-Week Range
$92.19 - $112.48
Dividend & Yield
$3.47 (3.21%)
NVS Stock Predictions, Articles, and Novartis Ag ADR News
PFE Stock: Ignore Pfizer Inc.’s Earnings Miss at Your Own Peril
Pfizer missed on earnings, and PFE stock slipped as a result. But even if you don't own Pfizer, you don't want to ignore what's happening there.
11 Pharmaceuticals Stocks to Sell Now
The ratings of 11 Pharmaceuticals stocks are down this week, according to the Portfolio Grader database. Each of these rates a "D" ("sell") or "F" overall ("strong sell").
11 Pharmaceuticals Stocks to Sell Now
This week, the overall grades of 11 Pharmaceuticals stocks are lower, according to the Portfolio Grader database. Each of these rates a "D" ("sell") or "F" overall ("strong sell").
Merck & Co., Inc. Features Slow and Steady Dividend Growth (MRK)
Merck is a blue-chip dividend stock that may be a solid investment, however MRK's dividend growth lags other competitors
11 Pharmaceuticals Stocks to Sell Now
This week, the ratings of 11 Pharmaceuticals stocks on Portfolio Grader are down. Each of these rates a "D" ("sell") or "F" overall ("strong sell").
10 Pharmaceuticals Stocks to Sell Now
The ratings of 10 Pharmaceuticals stocks are down this week, according to the Portfolio Grader database. Each of these rates a "D" ("sell") or "F" overall ("strong sell").
Why Johnson & Johnson Is a Top Dow Pick (JNJ)
A study of analyst recommendations shows that Johnson & Johnson is the #17 broker pick, on average, out of the 30 stocks making up the Dow
STUDY: Dementia Risk Linked to Popular Heartburn Drugs
Several heartburn drugs known as proton pump inhibitors are being linked to increased risk of dementia, according to a study published JAMA Neurology.
60 Recommendations for the Earnings Shakeout
these times it pays to stay on top of the latest profit opportunities. Today's post is be the place to start with these 70 stock moves
28 Trades to Start 2016
During these times, it pays to stay on top of the profit opportunities. Today's post is a place to start with these stocks to buy and sell
Trade of the Day: It’s Not Too Late to Short NVS Stock
Traders can expect more selling in Novartis AG (ADR).
These 51 Blue Chip Stocks Are On the Move
Having updated information on stocks is a key to investment success. Get started with updated rating on these 51 Blue Chip stocks
Hottest Healthcare Stocks Now – NLNK ARIA ISIS LCI
Healthcare stocks finished up 1.5% on Wall Street on Wednesday.
Trade of the Day: NVS Stock Not Making the Cut – Sell Now
Slowing sales growth and a chart breakdown do not bode well for Novartis AG (ADR).
Hottest Healthcare Stocks Now – NVS SNY SNN TARO
Healthcare stocks rose 0.3% on Wall Street on Wednesday morning.
U.S. Debut of Biosimilar Drugs Threatens Major Biotechs
The introduction of biosimilar drugs will change the biotech landscape ... especially for these three names.
